1Fromm GL, Gershenson DM, Silva EG. Papillary serous carcinoma of the peritoneum. Obstet Gynecol, 1990,75:89-95.
2Bloss JD, Liao SY, Buller RE, et al. Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol,1993,50:347-351.
3Swerdlow M. Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary; case report.Am J Obstet Gynecol,1959,77:197-200.
4Eltabbakh GH, Piver MS, Natarajan N, et al. Epidemiologic differences between women with extraovarian primary peritoneal carcinoma and women with epithelial ovarian cancer. Obstet Gynecol,1998,91:254-259.
5Bloss JD, Brady MF, Liao SY, et al. Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma-a Gynecologic Oncology Group Study. Gynecol Oncol,2003,89:148-154.
6Piver MS, Jishi MF, Tsukada Y, et al. Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry. Cancer,1993,71: 2751-2755.
7Piver MS, Eltabbakh GH, Hempling RE, et al. Two sequential studies for primary peritoneal carcinoma: induction with weekly cisplatin followed by either cisplatin-doxorubicin-cyclophosphamide or paclitaxel-cisplatin. Gynecol Oncol, 1997,67:141-146.
8Altaras MM, Aviram R, Cohen I, et al. Primary peritoneal papillary serous adenocarcinoma: clinical and management aspects. Gynecol Oncol,1991,40:230-236.
9Muto MG, Welch WR, Mok SC, et al. Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum. Cancer Res,1995, 55:490-492.
10Eltabbakh GH, Werness BA, Piver S, et al. Prognostic factors in extraovarian primary peritoneal carcinoma. Gynecol Oncol, 1998,71:230-239.
1Bloss J D, Liao S Y, Buller R E, et al. Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary [ J ]. Gynecol Oncol, 1993,50(3) :347 -51.
2Liu Q, Liu Q L, Wu B, et al. Primary peritoneal serous papillary carcinoma: a clinical and pathological study [ J ]. Pathol Oncol Res, 2011,17(3) :713 -9.
3Chao K C, Chen Y J, Juang C M, et al. Prognosis for advancedstage primary peritoneal serous papillary carcinoma and serous ovarian cancer in Taiwan[ J]. Taiwan J Obstet Gynecol, 2013,52 (1):81 -4.
4Yang X J, Huang C Q, Suo T, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final resuits of a phase Ⅲ randomized clinical trial[ J]. Ann Surg Oncol, 2011,18(6) :1575 -81.
5Isik A F, Sanli M, Yilmaz M, et al. Intrapleural hyperthermic perfusion chemotherapy in subjects with metastatic pleural malignancies[Jl. Respir ned, 2013,107(5):762 -7.
